ArticleHeliyon2024

Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia.

Hessa Tamim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.